Your browser doesn't support javascript.
loading
Effects of a low-carbohydrate diet in adults with type 1 diabetes management: A single arm non-randomised clinical trial.
Turton, Jessica L; Brinkworth, Grant D; Parker, Helen M; Lim, David; Lee, Kevin; Rush, Amy; Johnson, Rebecca; Rooney, Kieron B.
Affiliation
  • Turton JL; Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
  • Brinkworth GD; CSIRO - Health and Biosecurity, Westmead, New South Wales, Australia.
  • Parker HM; Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
  • Lim D; Church Street Medical Practice, Newtown, New South Wales, Australia.
  • Lee K; Qscan Group, Clayfield, Queensland, Australia.
  • Rush A; Type 1 Diabetes Family Centre, Stirling, Western Australia, Australia.
  • Johnson R; Type 1 Diabetes Family Centre, Stirling, Western Australia, Australia.
  • Rooney KB; Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
PLoS One ; 18(7): e0288440, 2023.
Article in En | MEDLINE | ID: mdl-37432920
ABSTRACT
Public interest in low-carbohydrate (LC) diets for type 1 diabetes (T1D) management has increased. This study compared the effects of a healthcare professional delivered LC diet compared to habitual diets higher in carbohydrates on clinical outcomes in adults with T1D. Twenty adults (18-70 yrs) with T1D (≥6 months duration) with suboptimal glycaemic control (HbA1c>7.0% or >53 mmol/mol) participated in a 16-week single arm within-participant, controlled intervention study involving a 4-week control period following their habitual diets (>150 g/day of carbohydrates) and a 12-week intervention period following a LC diet (25-75 g/day of carbohydrates) delivered remotely by a registered dietitian. Glycated haemoglobin (HbA1c -primary outcome), time in range (blood glucose 3.5-10.0 mmol/L), frequency of hypoglycaemia (<3.5 mmol/L), total daily insulin, and quality of life were assessed before and after the control and intervention periods. Sixteen participants completed the study. During the intervention period, there were reductions in total dietary carbohydrate intake (214 to 63 g/day; P<0.001), HbA1c (7.7 to 7.1% or 61 to 54 mmol/mol; P = 0.003) and total daily insulin use (65 to 49 U/day; P<0.001), increased time spent in range (59 to 74%; P<0.001), and improved quality of life (P = 0.015), with no significant changes observed during the control period. Frequency of hypoglycaemia episodes did not differ across timepoints, and no episodes of ketoacidosis or other adverse events were reported during the intervention period. These preliminary findings suggest that a professionally supported LC diet may lead to improvements in markers of blood glucose control and quality of life with reduced exogenous insulin requirements and no evidence of increased hypoglycaemia or ketoacidosis risk in adults with T1D. Given the potential benefits of this intervention, larger, longer-term randomised controlled trials are warranted to confirm these findings. Trial Registration https//www.anzctr.org.au/ACTRN12621000764831.aspx.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Hypoglycemia / Ketosis Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Hypoglycemia / Ketosis Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2023 Document type: Article Affiliation country:
...